Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025
04:05pm, Wednesday, 22'nd Oct 2025
MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wedne
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
11:11am, Monday, 20'th Oct 2025
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:16pm, Tuesday, 14'th Oct 2025
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.59, marking a -1.85% move from the previous day.
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
06:05am, Tuesday, 14'th Oct 2025
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than
PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project
09:05am, Monday, 13'th Oct 2025
More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicine More than 1,000 Korean genomes to be sequenced for global reference sta
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
11:06am, Friday, 10'th Oct 2025
PACB's Q2 beat, expanding Revio and Vega systems and growing clinical traction highlight its innovation-led recovery despite longer purchasing cycles.
PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell
01:46pm, Wednesday, 08'th Oct 2025
PACB expands seqWell partnership to enhance its sequencing workflow offerings with a new multiplexing kit.
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
09:05am, Wednesday, 08'th Oct 2025
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio's Revio system, powering one of the largest studies of healthy aging to date Up to 7,800 whole genomes and epigenomes to be sequenced
PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs
09:05am, Tuesday, 07'th Oct 2025
Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbial sequencing Highly scalable,
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
07:16pm, Monday, 06'th Oct 2025
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.52, marking a +2.01% move from the previous day.
PacBio Enters Carrier Screening Market With PureTarget Expansion
11:05am, Tuesday, 30'th Sep 2025
PACB expands its PureTarget portfolio, streamlining carrier screening with HiFi sequencing to meet rising global demand.
Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts
07:15pm, Monday, 22'nd Sep 2025
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.29, indicating a +1.57% shift from the previous trading day.
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
09:05am, Monday, 22'nd Sep 2025
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening Enhanced PureTarget portfolio replaces the need for multiple tests with
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
07:16pm, Friday, 12'th Sep 2025
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.17, denoting a -7.14% move from the preceding trading day.
Pacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
02:45pm, Wednesday, 10'th Sep 2025
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT Company Participants Christian Henry - President, CEO & D
